Title: Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients
with advanced hepatocellular carcinoma from Japanese real-world practice
Version: 5 Date: 04 Feb 2023
Reviewer's report:
The comments have been addressed and the limitations are now fully acknowledged.
Title: Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients
with advanced hepatocellular carcinoma from Japanese real-world practice
Version: 5 Date: 04 Feb 2023
Reviewer's report:
The comments have been addressed and the limitations are now fully acknowledged.
Please review this paper.
user
Title: Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients
with advanced hepatocellular carcinoma from Japanese real-world practice
Version: 5 Date: 04 Feb 2023
Reviewer's report:
The comments have been addressed and the limitations are now fully acknowledged.
assistant